Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BJU International|September 8, 2007
A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndromeDudley Robinson, Linda Cardozo, Gerben Terpstra, et al.
BJU International|October 13, 2009
Efficacy of simplified bladder training in patients with overactive bladder receiving a solifenacin flexible-dose regimen: results from a randomized studyAnders Mattiasson, Alberto Masala, Richard Morton, et al.
BMJ Open|December 26, 2024
Has the UK lost its position as a destination for world-leading clinical research? A comparative analysis of haematological cancer clinical trials performance before BrexitMeena Arora, Adrian Kilcoyne, John Bolodeoku, et al.
Current Medical Research and Opinion|June 21, 2008
A cost-utility analysis of once daily solifenacin compared to tolterodine in the treatment of overactive bladder syndromeMark Speakman, Vik Khullar, Anthony Mundy, et al.
Qatar Medical Journal|September 19, 2025
Thyroglobulin as an adjunct biomarker for assessing thyroid function during pregnancyTerry Gbaa, Simeon Adebisi, John Bolodeoku, et al.
Expert Opinion on Drug Safety|September 15, 2009
Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mgKeith A Wesnes, Chris Edgar, Reiner N Tretter, et al.
Journal of Pharmaceutical Policy and Practice|June 18, 2026
A mixed-methods evaluation of the quantitative and perceived impact of Brexit on UK oncology clinical trial initiation between 2011 and 2020Meena Arora, Sean Elliott, Adrian Kilcoyne, et al.
Pharmaceutics|December 18, 2020
Characterisation of Drug Delivery Efficacy Using Microstructure-Assisted Application of a Range of APIsRaha Rahbari, Ionut Ichim, Ryan Bamsey, et al.
Clinical Therapeutics|August 6, 2016
Demographic and Clinical Characteristics of Patients With Type 2 Diabetes Mellitus Initiating Dipeptidyl Peptidase 4 Inhibitors: A Retrospective Study of UK General PracticeAbigail Tebboth, Sally Lee, Anna Scowcroft, et al.
BJU International|November 8, 2008
Solifenacin in the treatment of urgency and other symptoms of overactive bladder: results from a randomized, double-blind, placebo-controlled, rising-dose trialLinda Cardozo, Elke Hessdörfer, Rodolfo Milani, et al.
Pageof 2